21 May 2009
Factors influencing the time to the occurrence of the first anxiety episode in heart transplant recipients
R Pudlo, M Piegza, M Zakliczyński, M ZembalaAnn Transplant 2009; 14(1): 64-64 :: ID: 880433
Abstract
Material/Methods: 36 heart transplant recipients have been evaluated during the first 8 weeks after OHT. Hamilton Anxiety Rating Scale was used every week in each patient. Cox regression analysis was used to specify, which of 11 studied demographic and medical factors could influence the time to the occurrence of the first anxiety episode. Kaplan-Meier curves enabled us to track the periods of the highest morbidity risk.
Results: The probability of anxiety during the first 8 weeks after the
transplantation was 52.5%. The first episode most commonly took place between the second and the fourth week after the transplantation. Anxiety syndrome took place earlier in patients with more numerous "false alarms" (number of requests to arrive to medical centre not finished with transplantation), and accompanying diseases. A strong anxiety occurred earlier in patients that had transplantation due to ischemic cardiomyopathy and in patients with more numerous "false alarms".
Conclusions: The first occurrence of anxiety episode is the most probable
between the second and the fourth week after transplantation. These episodes occur earlier in patients with accompanying somatic diseases, in patients that had transplantation due to ischemic cardiomyopathy and in persons that had more numerous "false alarms".
Keywords: Heart Transplantation
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






